Dominique Valeyre Selected Research

Infections

1/2022	Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
1/2017	The Lung in Dysregulated States of Humoral Immunity.
2/2016	Extrathoracic investigation in adult patients with isolated pulmonary langerhans cell histiocytosis.
2/2009	[The infectious complications of sarcoidosis].
2/2008	Efficiency of hydroxychloroquine in the treatment of granulomatous complications in chronic granulomatous disease.
6/2005	[Lung transplantation in patients with pulmonary fibrosis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominique Valeyre Research Topics

Disease

54	Sarcoidosis (Schaumann Disease) 12/2022 - 10/2002
26	Idiopathic Pulmonary Fibrosis 01/2022 - 04/2003
11	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 09/2007
11	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 08/2002
9	Connective Tissue Diseases (Connective Tissue Disease) 01/2017 - 05/2005
8	Neoplasms (Cancer) 01/2022 - 05/2005
8	Fibrosis (Cirrhosis) 01/2021 - 02/2007
6	Infections 01/2022 - 06/2005
6	Lung Diseases (Lung Disease) 12/2016 - 06/2005
5	Granuloma 01/2021 - 02/2006
4	Pulmonary Sarcoidosis 01/2021 - 06/2004
4	Disease Progression 01/2021 - 01/2016
4	Hypoxia (Hypoxemia) 01/2021 - 04/2003
4	Hypercalcemia (Milk Alkali Syndrome) 03/2014 - 11/2007
3	Pneumonia (Pneumonitis) 10/2021 - 01/2013
3	Rheumatoid Arthritis 07/2021 - 01/2011
3	Fever (Fevers) 07/2021 - 03/2009
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 01/2018
3	Pulmonary Hypertension 01/2020 - 01/2017
3	Edema (Dropsy) 01/2018 - 06/2005
3	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 03/2015 - 06/2010
3	Systemic Scleroderma (Systemic Sclerosis) 01/2011 - 09/2007
2	COVID-19 12/2022 - 01/2021
2	Fatigue 01/2021 - 07/2009
2	Necrosis 03/2020 - 12/2013
2	Immunoglobulin Light-chain Amyloidosis 11/2019 - 06/2012
2	Exanthema (Rash) 01/2019 - 05/2011
2	Inflammation (Inflammations) 01/2018 - 02/2006
2	Neurosarcoidosis 05/2017 - 12/2016
2	Idiopathic Interstitial Pneumonias 01/2017 - 10/2002
2	Lymphopenia (Lymphocytopenia) 01/2015 - 02/2009
2	Dermatomyositis (Dermatopolymyositis) 10/2014 - 05/2005
2	Berylliosis 09/2014 - 01/2013
2	Respiratory Insufficiency (Respiratory Failure) 01/2014 - 04/2003
2	Tuberculosis (Tuberculoses) 12/2013 - 01/2013
2	Lung Neoplasms (Lung Cancer) 01/2013 - 03/2011
2	Hyperprolactinemia 10/2012 - 09/2007
1	Cystitis 01/2022
1	Headache (Headaches) 07/2021
1	Endocarditis 07/2021
1	Scotoma (Scintillating Scotoma) 07/2021
1	Vertigo (Positional Vertigo) 07/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Hemolytic Anemia 01/2021
1	Anemia 01/2021
1	Hemolysis 01/2021

Drug/Important Bio-Agent (IBA)

20	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 07/2003
9	Pharmaceutical PreparationsIBA 01/2021 - 07/2009
9	pirfenidoneIBA 01/2019 - 05/2011
6	Biological ProductsIBA 05/2021 - 03/2011
6	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2013
5	AntigensIBA 01/2022 - 02/2006
5	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 05/2008
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2010
5	Infliximab (Remicade)FDA Link 03/2020 - 01/2017
4	GlucocorticoidsIBA 12/2022 - 01/2013
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 09/2007
4	Oxygen (Dioxygen)IBA 01/2021 - 02/2010
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 06/2005
4	SteroidsIBA 05/2017 - 12/2011
4	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2017 - 01/2011
4	Carbon MonoxideIBA 09/2012 - 04/2003
3	MineralsIBA 01/2022 - 01/2018
3	CytokinesIBA 01/2021 - 02/2006
3	Azathioprine (Imuran)FDA LinkGeneric 01/2019 - 06/2008
3	Tumor Necrosis Factor InhibitorsIBA 01/2018 - 01/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2017
3	InterferonsIBA 12/2013 - 04/2003
2	CalciumIBA 10/2021 - 03/2014
2	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 10/2014
2	cyclopropapyrroloindoleIBA 01/2020 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 11/2019 - 06/2012
2	EnzymesIBA 01/2018 - 02/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2016 - 08/2015
2	telomerase RNA (bTR)IBA 12/2016 - 08/2015
2	CarbohydratesIBA 04/2016 - 02/2013
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2015 - 11/2007
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2014 - 10/2008
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2003 - 08/2002
1	Mesna (Coenzyme M)FDA LinkGeneric 01/2022
1	Etanercept (Enbrel)FDA Link 07/2021
1	Plasminogen Activator Inhibitor 1IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Prostaglandins AIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	CarboxyhemoglobinIBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2020

Therapy/Procedure

23	Therapeutics 07/2021 - 04/2003
6	Lung Transplantation 01/2021 - 04/2003
3	Transplantation 01/2018 - 06/2005
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2014
2	Pneumonectomy (Lung Volume Reduction) 01/2018 - 03/2011
2	Drug Therapy (Chemotherapy) 12/2012 - 03/2011
1	Heart-Lung Transplantation 01/2021
1	Biological Therapy 03/2020